Synthon International Holding Overview
- Year Founded
-
1991
- Status
-
Private
- Employees
-
1,600
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
5
Synthon International Holding General Information
Description
Operator of a pharmaceutical company intended to specialize in developing and manufacturing quality generic medicines for patients around the world. The company specializes in developing and manufacturing generic and hybrid medicines, enabling medical professionals to help improve the health and well-being of their patients.
Contact Information
Website
www.synthon.comCorporate Office
- Microweg 4, Building L
- 6545 CM Nijmegen
- Netherlands
Corporate Office
- Microweg 4, Building L
- 6545 CM Nijmegen
- Netherlands
Synthon International Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Synthon International Holding Comparisons
Industry
Financing
Details
Synthon International Holding Competitors (38)
One of Synthon International Holding’s 38 competitors is Glenmark Farmacêutica, a Corporation company based in Sao Paulo, Brazil.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glenmark Farmacêutica | Corporation | Sao Paulo, Brazil | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Pil-psychotropics India | Corporation | Faridabad, India | ||||
| Lannett | Corporate Backed or Acquired | Trevose, PA | ||||
| Beloteca | Corporation | San Diego, CA |
Synthon International Holding Patents
Synthon International Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260138954-A1 | Amorphous solid form and pharmaceutical compositions of lenvatinib besylate | Pending | 18-Aug-2025 | ||
| WO-2026027799-A2 | Amorphous solid form and pharmaceutical compositions of lenvatinib besylate | Pending | 18-Aug-2025 | ||
| WO-2026027799-A3 | Amorphous solid form and pharmaceutical compositions of lenvatinib besylate | Pending | 18-Aug-2025 | ||
| WO-2026234202-A1 | Process for preparation of asciminib | Pending | 09-May-2025 | ||
| WO-2026202057-A1 | Particles of l-arginine salt of etrasimod | Pending | 24-Mar-2025 | C07D209/94 |
Synthon International Holding Signals
Synthon International Holding Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Synthon International Holding Investments & Acquisitions (5)
Synthon International Holding’s most recent deal was a Buyout/LBO with Synthon International Holding (6,000 Meter Square Facility in Spain). The deal was made on 29-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Synthon International Holding (6,000 Meter Square Facility in Spain) | 29-Jun-2026 | Buyout/LBO | Buildings and Property | ||
| Biolex Therapeutics (Lex System Operations) | 20-Apr-2012 | Merger/Acquisition | Drug Discovery | ||
| Syntarga | 23-Jun-2011 | Merger/Acquisition | Drug Discovery | ||
| Naf Laboratorio | 08-Mar-2010 | Merger/Acquisition | Drug Discovery | ||
| Synthon Chile | 11-Jun-2007 | Merger/Acquisition | Pharmaceuticals |
Synthon International Holding Exits (1)
Synthon International Holding’s most recent exit was on 08-Mar-2010 from Naf Laboratorio. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Naf Laboratorio | 08-Mar-2010 | Completed |
|
Synthon International Holding Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Syntarga | Nijmegen, Netherlands | 2002 |
Synthon International Holding FAQs
-
When was Synthon International Holding founded?
Synthon International Holding was founded in 1991.
-
Where is Synthon International Holding headquartered?
Synthon International Holding is headquartered in Nijmegen, Netherlands.
-
What is the size of Synthon International Holding?
Synthon International Holding has 1,600 total employees.
-
What industry is Synthon International Holding in?
Synthon International Holding’s primary industry is Pharmaceuticals.
-
Is Synthon International Holding a private or public company?
Synthon International Holding is a Private company.
-
What is the current valuation of Synthon International Holding?
The current valuation of Synthon International Holding is .
-
What is Synthon International Holding’s current revenue?
The current revenue for Synthon International Holding is .
-
How much funding has Synthon International Holding raised over time?
Synthon International Holding has raised $499M.
-
Who are Synthon International Holding’s investors?
Goldman Sachs Asset Management has invested in Synthon International Holding.
-
Who are Synthon International Holding’s competitors?
Glenmark Farmacêutica, Evonile Pharma, Pil-psychotropics India, Lannett, and Beloteca are some of the 38 competitors of Synthon International Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process